Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
Biomaterials. 2011 Dec;32(35):9155-8. doi: 10.1016/j.biomaterials.2011.09.047. Epub 2011 Oct 1.
Iron-oxide nanoparticles facilitate cancer diagnosis through enhanced contrast, selectively enhance tumor cell death with magnetic hyperthermia, and improve drug delivery with magnetic drug targeting. One application that remains largely unexplored is using the iron-oxide nanoparticles themselves to selectively inhibit tumor growth. In this leading opinion paper, we propose that high doses of iron-oxide nanoparticles can be used as a treatment for cancer by generating an oxidative assault against cancer. This proposal may be met with resistance considering the controversy surrounding iron in the field of cancer. Iron generates reactive oxygen species through the Fenton reaction, which may both cause - or cure cancer. Additionally, high demand for iron by cancer cells leads to contradictory therapeutic approaches: iron deprivation or overdose are both potential cancer therapies.
氧化铁纳米颗粒通过增强对比度促进癌症诊断,通过磁热疗选择性增强肿瘤细胞死亡,并通过磁靶向药物递送改善药物输送。一个尚未得到充分探索的应用是利用氧化铁纳米颗粒本身选择性抑制肿瘤生长。在这篇主要观点文章中,我们提出高剂量的氧化铁纳米颗粒可以通过对癌细胞发起氧化攻击来治疗癌症。考虑到癌症领域中存在的关于铁的争议,这一建议可能会遭到反对。铁通过芬顿反应产生活性氧,这可能会导致癌症或治愈癌症。此外,癌细胞对铁的高需求导致了相互矛盾的治疗方法:缺铁或铁过量都是潜在的癌症治疗方法。